Phasebio Pharmaceuticals Inc (PHAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | PHAS | BMY | AMGN | GILD | VRTX |
Company | Phasebio Pharmaceuticals Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
Price Information | |||||
Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
Open | 0.0800 | 44.68 | 265.72 | 65.50 | 393.52 |
High | 0.0920 | 45.37 | 271.68 | 66.35 | 399.68 |
Low | 0.0665 | 44.34 | 265.72 | 64.63 | 393.49 |
Last | 0.0701 | 44.85 | 269.98 | 65.42 | 397.48 |
Change | -0.0249 | +0.15 | +0.60 | +0.15 | -0.22 |
% Change | -26.21% | +0.34% | +0.22% | +0.23% | -0.06% |
Volume | 9,647,400 | 19,903,273 | 2,172,725 | 12,211,058 | 654,759 |
20-Day Average Volume | 3,930,150 | 12,811,029 | 2,096,692 | 6,927,986 | 929,666 |
Previous Close | 0.0950 | 44.70 | 269.38 | 65.27 | 397.70 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | No | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 0.1610 | 49.48 | 270.04 | 68.30 | 401.27 |
20-Day Raw Stochastic | 2.27% | 6.83% | 44.38% | 10.07% | 20.63% |
20-Day Relative Strength | 20.88% | 30.05% | 46.55% | 29.65% | 42.40% |
Weighted Alpha | -91.26 | -34.09 | +10.02 | -23.36 | +14.70 |
Today's Opinion | 100% Sell | 88% Sell | 56% Sell | 100% Sell | 8% Buy |
Previous Opinion | 100% Sell | 88% Sell | 72% Sell | 100% Sell | 8% Buy |
Last Month's Opinion | 72% Sell | 8% Buy | 40% Buy | 88% Sell | 56% Buy |
Performance | |||||
5-Days | |||||
%Chg | -42.40% since 10/26/22 | -8.00% since 04/19/24 | +0.77% since 04/19/24 | -1.89% since 04/19/24 | +0.76% since 04/19/24 |
Low | 0.0665 on 11/02/22 | 44.34 on 04/26/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 393.00 on 04/25/24 |
High | 0.1440 on 10/27/22 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 406.86 on 04/23/24 |
1-Month | |||||
%Chg | -60.17% since 09/30/22 | -14.34% since 03/26/24 | -3.83% since 03/26/24 | -9.55% since 03/26/24 | -5.06% since 03/26/24 |
Low | 0.0665 on 11/02/22 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 |
High | 0.2250 on 10/14/22 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 |
3-Month | |||||
%Chg | -93.85% since 08/02/22 | -9.43% since 01/26/24 | -13.08% since 01/26/24 | -17.64% since 01/26/24 | -7.64% since 01/26/24 |
Low | 0.0665 on 11/02/22 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 |
High | 1.3800 on 08/09/22 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 448.40 on 01/30/24 |
6-Month | |||||
%Chg | -94.35% since 05/02/22 | -15.02% since 10/26/23 | +0.47% since 10/26/23 | -16.57% since 10/26/23 | +9.97% since 10/26/23 |
Low | 0.0665 on 11/02/22 | 44.34 on 04/26/24 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 341.90 on 11/16/23 |
High | 1.3800 on 08/09/22 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
Key Statistics | |||||
Market Capitalization, $K | 3,495 | 90,596,128 | 144,488,960 | 81,266,176 | 102,789,152 |
Shares Outstanding, K | 49,858 | 2,026,759 | 536,376 | 1,245,077 | 258,459 |
Annual Sales | 10,830,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
Annual Net Income | -131,070,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
Last Quarter Sales | 210,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 |
Last Quarter Net Income | -16,670,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 968,800,000 |
60-Month Beta | 2.57 | 0.39 | 0.58 | 0.19 | 0.35 |
Per-Share Information | |||||
Most Recent Earnings | -0.34 on 08/12/22 | -4.40 on 04/25/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 4.20 on 02/05/24 |
Latest Earnings Date | 11/09/22 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 6.51 | 14.64 | 9.98 | 29.82 |